| Literature DB >> 24532665 |
Ruben Esse1, Apolline Imbard2, Cristina Florindo3, Sapna Gupta4, Eoin P Quinlivan5, Mariska Davids6, Tom Teerlink6, Isabel Tavares de Almeida7, Warren D Kruger4, Henk J Blom8, Rita Castro7.
Abstract
Accumulation of the homocysteine (Hcy) precursor S-adenosylhomocysteine (AdoHcy) may cause cellular hypomethylation in the setting of hyperhomocysteinemia because of cystathionine β-synthase (CBS) deficiency, an inborn error of metabolism. To test this hypothesis, DNA and protein arginine methylation status were assessed in liver, brain, heart, and kidney obtained from a previously described mouse model of CBS deficiency. Metabolite levels in tissues and serum were determined by high-performance liquid chromatography or liquid chromatography-electrospray ionization-tandem mass spectrometry. Global DNA and protein arginine methylation status were evaluated as the contents of 5-methyldeoxycytidine in DNA and of methylarginines in proteins, respectively. In addition, histone arginine methylation was assessed by Western blotting. CBS-deficient mice exhibited increased (>6-fold) Hcy and AdoHcy levels in all tissues examined compared with control levels. In addition, global DNA methylation status was not affected, but global protein arginine methylation status was decreased (10-35%) in liver and brain. Moreover, asymmetric dimethylation of arginine 3 on histone H4 (H4R3me2a) content was markedly decreased in liver, and no differences were observed for the other histone arginine methylation marks examined. Our results show that CBS-deficient mice present severe accumulation of tissue Hcy and AdoHcy, protein arginine hypomethylation in liver and brain, and decreased H4R3me2a content in liver. Therefore, protein arginine hypomethylation arises as a potential player in the pathophysiology of CBS deficiency. © FASEB.Entities:
Keywords: H4R3me2a; S-adenosylhomocysteine; homocystinuria; methylarginines
Mesh:
Substances:
Year: 2014 PMID: 24532665 PMCID: PMC4021445 DOI: 10.1096/fj.13-246579
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191